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Insulin-loaded nanoparticles were prepared by ionotropic pre-gelation of alginate with calcium chloride followed by complexation
between alginate and chitosan. The influence of the pH and stoichiometry relationship between polyelectrolytes providing individual par-
ticles with a nano-scale size was assessed by photon correlation spectroscopy (PCS) and scanning electron microscopy (SEM). Insulin–
polyelectrolyte interactions at varying pH and polyelectrolytes stoichiometry were assessed by differential scanning calorimetry (DSC)
and Fourier-transform infrared (FTIR) studies. Individual and smaller sizing nanoparticles, around 800 nm, were obtained at pH 4.7
with an alginate:chitosan mass ratio of 6:1. Thermograms of insulin-loaded nanoparticles originated shifts on same unloaded nanopar-
ticle peaks and suggested polyelectrolytes–protein interactions at pH around 4.5–5.0. FTIR spectra of insulin-loaded nanoparticles
showed amide absorption bands characteristic of protein spectra and revealed the formation of new chemical entities.
 2006 Elsevier Ltd. All rights reserved.
Keywords: Alginate; Chitosan; DSC; FTIR; Insulin; Nanoparticles1. Introduction
Nanoparticles made of polyelectrolytes complexation
have shown potential for use as drug delivery systems.
Polyelectrolyte complexes (PEC) are formed when oppo-
sitely charged polyelectrolytes are mixed and interact via
electrostatic interactions. Chitosan and alginate are polyca-
tion and polyanion polyelectrolytes, respectively, that can
be used to form a polyelectrolyte complex and to deliver
proteins (Sarmento et al., in press), peptidic drugs (Coppi,
Iannuccelli, Leo, Bernabei, & Cameroni, 2001) and DNA
(Douglas & Tabrizian, 2005).
The interaction between alginate in dilute solution with
Ca2+ occurs at a certain ion concentration (Rajaonarivony,
Vauthier, Couarraze, Puisieux, & Couvreur, 1993). A pre-
gel state results with stirring, avoiding the gel point and0144-8617/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
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E-mail address: bruno.sarmento@ff.up.pt (B. Sarmento).forming a continuous system. Subsequent addition of an
aqueous polycationic solution (chitosan) results in a poly-
electrolyte complex, stabilizing the alginate pre-gel nucleus
into individual sponge-like nanoparticles (Sarmento,
Ribeiro, Veiga, Neufeld, & Ferreira, 2005).
Many studies have been published on individual chito-
san–alginate systems (De & Robinson, 2003; Lee, Park,
& Ha, 1997). Although parameters such as the molecular
weight, temperature, and pH have been studied to some
extent, most of these studies are performed under specific
and limited pH and stoichiometric conditions. Few
attempts have been made to compare the properties of
complexes formed between chitosan and alginate with
and without protein and to rationalize the results in terms
of the molecular properties of the protein-containing
complexes.
The use of polyelectrolyte complexes as protein delivery
systems may result in an overall higher level of electrostatic
interactions due to the presence of protein. The control of
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biological activity of encapsulant has been reported (Silva,
Ribeiro, Figueiredo, Goncalves, & Veiga, 2006).
Differential scanning calorimetry (DSC) can be used to
characterize the thermal behaviour of polyelectrolytes
and biomolecules which is correlated to their structure,
hydrophilic properties and association state. It is based
on the heat capacity of the sample as a function of the tem-
perature. It is possible in one experiment to obtain the
complete temperature profile of the Gibbs energy change
associated with the loss of water in polymers, with the
denaturation process in proteins and with depolymeriza-
tion at high temperatures. Shifts of exothermic and endo-
thermic peaks are usually associated with interactions
between drugs and polymer (Borges, Borchard, Verhoef,
Sousa, & Junginger, 2005; Ribeiro, Silva, Ferreira, &
Veiga, 2005; Wong, Chan, Kho, & Heng, 2002).
Fourier transform infrared (FTIR) analysis has also
been proposed to examine interactions between polyelec-
trolyte complexes (Dupuy, Arien, & Minnot, 1994; Ribeiro
et al., 2005).
With these series of experiments it was intended to mon-
itorize the complexation of contrary charged polyelectro-
lytes as insulin nanoparticulate carriers. Systems resulting
from complexation of polyelectrolytes at varying pH and
stoichiometric relationship between polyelectrolytes were
lyophilized, and analyzed by DSC and FTIR to verify
interactions between polyelectrolytes and between poly-
mers and insulin.
2. Materials and methods
Low viscosity sodium alginate with a low guluronic con-
tent (FG = 0.39), low molecular weight (MW) chitosan
(50 kDa) and calcium chloride were purchased from
Sigma (Oakville, Canada). Alginate solution was prepared
in deionized water (Milli-Q) overnight under magnetic
stirring and chitosan sample was dissolved in 1% acetic
acid solution in deionized water followed by filtration by
using a Millipore #2 paper filter and stored at 4 C. Human
zinc–insulin crystal was a gift from Lilly Farma, Portugal.
2.1. Nanoparticle preparation
Alginate/chitosan nanoparticles were prepared in a two-
step procedure based on the ionotropic pre-gelation of
polyanion with calcium chloride followed by polycation-
ic crosslinking through a protocol earlier described
(Rajaonarivony et al., 1993), modified according to ideal
pre-gelation stoichiometric ratio and time of drug associa-
tion (Sarmento et al., 2005). Thus, 7.5 ml of 18 mM calci-
um chloride solution was dropped for 60 min under
800 rpm into a beaker containing 117.5 ml of a 0.063%
(w/w) alginate solution. An amount of insulin equivalent
to 200 UI was mixed with the alginate solution before cal-
cium chloride addition to provide an alginate pre-gel.
Then, 25 ml of different concentration (0.05–0.09%, w/w)chitosan solution was added dropwise into the pre-gel over
120 min. The pH of alginate and chitosan solutions was ini-
tially set to 4.9 and 4.6 to provide a colloidal dispersion
with final pH of 4.7, but further modified to provide a final
pH of 4.2 and 5.2. Nanoparticles were held with an addi-
tional stirring for 30 min to improve curing, and separated
by centrifugation (20000g/45 min) at 4 C.
2.2. Nanoparticle characterization
2.2.1. Morphology
Nanoparticles granulometry was assessed by PCS using
a Malvern Zetasizer and Scattering Particle Size Analyzer
(Malvern Instruments, UK). A sample of 5 ml was gently
shaked, placed into analyzer chamber and measured. Col-
lective 10 readings were performed three times on a sample
of particles at 25 C with a detection angle of 90.
Nanoparticulate systems morphology such as shape and
occurrence of aggregation phenomena, was studied by
scanning electron microscopy (SEM). Samples of nanopar-
ticles were mounted on metal stubs, gold coated under vac-
uum and then examined on a JEOL JSM-840 SEM (10 kV,
Japan).
2.2.2. FTIR analysis
IR-spectra were obtained using a Bomem IR-spectrom-
eter (Bomem, Canada). Samples were lyophilized, gently
mixed with 300 mg of micronized KBr powder and com-
pressed into discs at a force of 10 kN for 2 min using a
manual tablet presser (Perkin Elmer, Norwalk, USA).
For each spectrum a 256-scan interferogram was collected
with a 4 cm1 resolution in the mid-IR region at room tem-
perature. Insulin spectra were obtained according to a
double subtraction procedure (Dong, Huang, & Caughey,
1990) and insulin-free systems and water vapor spectra
were collected under identical conditions for blank subtrac-
tion. All samples were run in triplicate and the data pre-
sented are the average of the three measurements.
2.2.3. DSC analysis
Thermograms were obtained using a Shimadzu DSC-50
system (Shimadzu, Kyoto, Japan). Samples were lyophi-
lized, 2.0 mg of lyophilized powder crimped in a standard
aluminium pan and heated from 20 to 350 C at a heating
constant rate of 10 C/min under constant purging of
nitrogen at 20 ml/min. All samples were run in duplicate.
3. Results and discussion
Particle size is determinant in mucosal and epithelial tis-
sue uptake of particles and in the intracellular traffic of the
particles (Panyam & Labhasetwar, 2003). Drug carriers siz-
ing few microns have shown higher potential as oral deliv-
ery systems of proteins and peptides (Chen & Langer,
1998). Granulometric distribution of chitosan–alginate
nanoparticles depend on concentration and molecular
weight of both polyelectrolytes, and conditions of mixing
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have shown an increasing size effect on nanoparticulate
carriers made of polyelectrolytes complexation. The effect
of chitosan to alginate mass ratio on particle size showed
an increase of size from 764 to 2209 nm with decreasing
chitosan to alginate mass ratio from 6:1 to 3.3:1. (Table 1).
These relationships provide a processing window for
manipulating particles in both nano and microsize range
and optimizing the nanosize for intended applications.
Also, nanoparticle size appears to present a relatively nar-
row distribution according to values of SD obtained and as
displayed in Fig. 1.
The effect of pH on nanoparticle size is shown in Table 2.
The pH range was chosen to allow contrary charges of
polyelectrolytes in order to provide the formation of nano-
particles. The decrease of pH from 5.2 to 4.7 slightly
decreased the mean particle size of obtained nanoparticles,
but the opposite effect was observed by decreasing the pH
from 4.7 to 4.2 since the mean size of particles significantly
increased when pH of aqueous solution reached values
around 4. It is believed that at this pH range, alginate
approaches its pKa values, the first of guluronic acid
around 3.7 (Haug, 1964), and a significant part of it starts
precipitating and aggregating, which may contribute to
increase the particle size mean value measured by PCS.Table 1
Characterization of alginate/chitosan nanoparticles produced at pH 4.7 in
terms of mean size (±SD) as a function of alginate/chitosan mass ratio
(n = 3)
Alginate:chitosan mass ratio Mean size (nm)
6:1 764 ± 76
4.3:1 797 ± 48
3.3:1 2209 ± 496
Size distribution(s)
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Fig. 1. Particle size analysis of insulin-loaded nanoparticles produced with
alginate:chitosan mass ratio of 4.3:1 at pH 4.7.Fig. 2 shows the SEM images of the chitosan–alginate
particles. Nanoparticle surface showed an irregular shape
and morphology related to a generic spherical shape.
Table 3 presents the endothermic and exothermic peaks
and enthalpies associated with each peak for insulin, algi-
nate, chitosan, physical mixtures, and nanoparticles
obtained by complexation of polyelectrolytes at pH 4.7.
Also, the thermogram of insulin-loaded alginate/chitosan
nanoparticles is summarized.
In Fig. 3 we can see the thermograms of alginate and
chitosan which show initial endothermic peaks at 86.6
and 62.0 C and higher exothermic peaks at 247.8 and
311.0 C, respectively. Endothermic peaks are correlated
with loss of water associated to hydrophilic groups of poly-
mers while exothermic peaks resulted from degradation of
polyelectrolytes due to dehydration and depolymerization
reactions most probably to the parcial decarboxilation of
the protonated carboxylic groups and oxidation reactions
of the polyelectrolytes (Mimmo, Marzadori, Montecchio,
& Gessa, 2005; Soares, Santos, Chierice, & Cavalheiro,
2004; Zohuriaan & Shokrolahi, 2004). Thermogram of
alginate/chitosan physical mixture show a broader endo-
thermic peak at 76.7 C, which probably represents the
coalescence of both isolated endothermic polymer peaks
and exothermic peaks at 250.4 and 309.6 C resulted from
individual contribution of alginate and chitosan,
respectively.Fig. 2. SEM micrographs of alginate/chitosan nanoparticles produced
with alginate:chitosan mass ratio of 4.3:1 at pH 4.7.
Table 2
Characterization of alginate/chitosan nanoparticles produced with algi-
nate:chitosan mass ratio of 4.3:1 in terms of mean size (±SD) as a function
of system’s final (n = 3)
pH of nanoparticle production Mean size (nm)
4.2 2858 ± 376
4.7 797 ± 48
5.2 1062 ± 210
Table 3
Peak temperatures and enthalpy changes in the DSC thermograms collected from insulin, polysaccharides, physical mixtures, and nanoparticles
Sample Temperature (C) DH (J/g)
Onset Peak Endset
Alginate 37.5 86.6 128.0 143.2
212.2 247.8 266.1 64.6
Chitosan 30.0 62.0 108.5 578.5
279.8 311.0 329.8 23.0
Alginate/chitosan physical mixture 32.8 76.5 116.4 387.2
231.8 250.4 263.4 159.2
290.2 309.6 324.5 59.5
Insulin 48.1 62.3 72.3 22.1
72.3 83.0 95.2 27.4
192.6 251.1 266.6 54.3
Alginate/insulin pregel 45.3 73.2 111.7 218.4
224.8 249.4 267.9 277.6
Alginate/chitosan nanoparticles 39.0 76.5 121.0 324.9
227.2 287.7 287.7 48.0
Insulin-loaded alginate/chitosan nanoparticles 36.2 72.9 108.5 210.5
206.2 281.8 281.8 67.1
Unloaded and insulin-loaded nanoparticles were obtained by chitosan/alginate complexation at pH 4.7 and mass ratio of 4.3:1.
0 50 100 150 200 250 300 350
309.6250.4
287.7
311.0
247.8
76.5
76.7
62.0
86.6
(d)
(c)
(b)
Ex
o
Temperature (ºC)
(a)
Fig. 3. Thermograms of (a) alginate at pH 4.9, (b) chitosan at pH 4.6, (c)
chitosan/alginate physical mixture, and (d) alginate/chitosan nanoparti-
cles produced at pH 4.7.
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Fig. 4. Thermograms of alginate/chitosan nanoparticles produced at (a)
pH 4.2, (b) 4.7, and (c) 5.2.
4 B. Sarmento et al. / Carbohydrate Polymers 66 (2006) 1–7It could be seen that the peaks of the complexes were
shifted from those of physical mixture. Peaks of physical
mixture appeared to be combinations of each material
but they are different from those of nanoparticles probably
because complexation of polyelectrolytes resulted in new
chemical bonds. Exothermic peak of alginate/chitosan
nanoparticles was registered at 287.7 C, an intermediate
and broader peak value compared with isolate polyelectro-
lytes, which was interpreted as an interaction between both
components.
Thermograms of alginate/chitosan nanoparticles pre-
pared at three different pH environments, are shown in
Fig. 4.Both endothermic and exothermic peaks shifted to high-
er temperature values when pH of nanoparticles prepara-
tion was decreased from 5.2 to 4.2. It can be realized that
at lower pH resulted higher stability of complexes, thus
more energy was required to remove residual water
adsorbed to nanoparticles (also endothermic peak shifts
to higher value), and less energy was released by braking
ionic interactions and during nanoparticle thermal decom-
position (also exothermic peak shift to higher value).
The pK values of mannuronic acid (M) and guluronic
acid (G) of alginate chain are pKM 3.38 and pKG 3.65,
respectively (Haug, 1964) and the pK value of chitosan is
6.3 (Berger et al., 2004). It was also found that amine
groups of chitosan polymer had more affinity to M residues
than G residues of alginate (Dupuy et al., 1994). The algi-
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Fig. 6. Thermograms of (a) insulin, (b) alginate at pH 4.9, and (c) insulin-
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which means that overall pK of alginate is close to pKM
and maximum ionic interaction between alginate and
chitosan is attained at lower pH as compared to a high-
G alginate. Also, alginate gel is shrinked at lower pH val-
ues and a reduction of the pore size of alginate matrix
can be achieved (Gombotz & Wee, 1998), specially in the
case of low G content alginate used in the present work
that acquire highest shrinkage properties. Therefore, at
pH 4.2 it is possible that nanoparticles presented a stronger
robustness that at pH 4.7 and more that pH 5.2, as ana-
lyzed. The interaction between alginate and chitosan is
known to be pH-dependent and stronger complexes were
also obtained at pH around 4.5–5.0 (Lee et al., 1997; Liu
et al., 2004).
The effect of alginate:chitosan mass ratio on the nano-
particles was also evaluated through calorimetry and
depicted in Fig. 5. By increasing the final amount of chito-
san on nanoparticles weight, it was observed an increase of
the value of exothermic peak. Nanoparticles produced with
alginate:chitosan mass ratio of 6:1, 4.3:1, and 3.3:1 present-
ed an exothermic peak at 270.1, 287.7, and 337.7 C,
respectively. However, the increasing effect of final amount
of chitosan on the value of initial endothermic peak was
less evident than the one observed for the influence of
pH. The results obtained could lead to the assumption that
decreasing alginate:chitosan mass ratio by increasing initial
chitosan mass on nanoparticles originated different degree
of interaction between polymers, suggesting the obtention
of more stable polyelectrolyte complexes with a higher
amount of chitosan.
The thermogram of zinc–insulin showed two endother-
mic peaks at 62.3 and 83.0 C and a tiny and broad exo-
thermic peak at 251.1 C. This thermogram pattern of
insulin is in agreement with other reported in literature
(Jorgensen, Weert, Vermehren, Bjerregaard, & Frokjaer,
2004; Pikal & Rigsbee, 1997). This biphasic denaturation0 50 100 150 200 250 300 350
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Fig. 5. Thermograms of alginate/chitosan nanoparticles produced with
alginate:chitosan mass ratio of (a) 6:1, (b) 4.3:1, and (c) 3.3:1.of the zinc–insulin complex is a result of the coupling
between insulin denaturation and zinc binding equilibria.
Comparing to zinc-free insulin, the endotherm of insulin
hexamers involves both dissociation and unfolding,
whereas the endotherm of zinc-free insulin does not show
dissociation behaviour (Huus, Havelund, Olsen, van de
Weert, & Frokjaer, 2005). Figs. 6 and 7 represent the ther-
mal differences of alginate pre-gel and alginate/chitosan
nanoparticles, respectively, before and after insulin
entrapment.
The two endothermic peaks associated to insulin which
are attributed to denaturation process and water loss,
became indistinct and transformed themselves into a single
peak after insulin entrapment into the alginate pre-gel and
alginate/chitosan nanoparticles. Insulin-loaded systems
reached this endothermic condition at lower temperature
values comparing to unloaded nanoparticles, thus an
interaction between the protein and the polyelectrolytesloaded alginate pre-gel.
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Fig. 7. Thermograms of (a) insulin (b) alginate/chitosan nanoparticles,
and (c) insulin-loaded alginate/chitosan nanoparticles produced at pH 4.7.
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Fig. 8. FTIR spectra of solid (a) alginate, (b) chitosan, and (c) alginate/
chitosan nanoparticles produced with alginate:chitosan mass ratio of 4.3:1
at pH 4.7.
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Fig. 9. FTIR spectra of solid (a) alginate/chitosan nanoparticles, (b)
insulin, and (c) insulin-loaded alginate/chitosan nanoparticles produced
with alginate:chitosan mass ratio of 4.3:1 at pH 4.7.
6 B. Sarmento et al. / Carbohydrate Polymers 66 (2006) 1–7could have occurred. Also, comparing exothermic peak of
insulin-loaded alginate/chitosan nanoparticles to the one
obtained with unloaded nanoparticles, the former started
at lower temperature, which is a possible evidence of the
presence of insulin once its decomposition started at lower
temperature 251.1 C when comparing to unloaded nano-
particles (Table 4).
In order to examine the relationship between compo-
nents of nanoparticulate systems, preliminary concerns
were taken over polyelectrolytes interactions and insulin
entrapment. It is well established that the carboxyl group
(–COO) of the anionic polymer may interact with the
amino group ð–NH3þÞ of chitosan and form an ionic com-
plex between the two compounds (Ribeiro et al., 2005). As
a result, there are changes in the FTIR spectra in the
absorption bands of the amino groups, carboxyl groups,
and amide bonds.
Fig. 8 represents FTIR spectra of pure alginate, chito-
san, and alginate/chitosan nanoparticles.
We can see alginate carboxyl peaks near 1613 cm1
(symmetric COO stretching vibration) and 1415 cm1
(asymmetric COO stretching vibration) broaden and
slightly shifted from 1613 to 1610 and 1415 to 1414 after
complexation with chitosan. The FTIR spectrum of
chitosan also shows a peak of amide bond at
1641 cm1 and a strong protonated amino peak at
1569 cm1 because it is obtained from partial N-deacety-
lation of chitin. However, both peaks were similarly
shifted by few cm1 after complexation with alginate,
the amide peak into singlet band at 1610 cm1 and the
amino peak to 1534 cm1. Observed changes in the
absorption bands of the amino groups, carboxyl groups,
and amide bonds can be attributed to an ionic interac-
tion between the carbonyl group of alginate and the ami-
no group of chitosan (Ribeiro et al., 2005). In addition,Table 4
Peak temperatures and enthalpy changes in the DSC thermograms
collected from nanoparticulate complexes obtained with a varying
stoichiometry of alginate/chitosan at varying pH
Sample Temperature (C) DH (J/g)
Onset Peak Endset
Alginate:chitosan mass ratio 4.3:1
pH 4.2 41.9 79.3 125.5 374.2
233.8 320.2 320.2 128.2
pH 4.7 39.0 76.5 121.0 324.9
227.2 287.7 287.7 48.0
pH 5.2 43.95 67.5 111.2 306.5
229.7 275.6 275.6 32.11
Alginate/chitosan nanoparticles pH 4.7
Alginate:chitosan mass ratio 6.0:1 44.6 73.4 112.9 448.1
224.0 286.8 292.8 89.55
Alginate:chitosan mass ratio 4.3:1 39.0 76.5 121.0 324.9
227.2 287.7 287.7 48.0
Alginate:chitosan mass ratio 3.3:1 39.2 75.9 101.2 200.9
305.5 337.7 346.8 8.73the peak absorbance of amino groups of chitosan at
1153 cm1 was also present after complexation and
absent in alginate. Similar observations were noted previ-
ously (Mitrevej, Sinchaipanid, Rungvejhavuttivittaya, &
Kositchaiyong, 2001). These results suggest an effective
interaction between polymers and seem to be in agree-
ment with the stoichiometric ratios between them indicat-
ing a prevalence of alginate in the final blend.
The introduction of insulin into nanoparticles was also
investigated by FTIR analysis of insulin-loaded nanoparti-
cles. The obtained spectra are represented in Fig. 9 and
revealed two shoulders on the nanoparticles absorption
bands in the Amide I (1650 cm1) and Amide II
(1540 cm1), which are characteristic of protein spectra.
The insulin monomer contains many ionizable groups,
due to six amino acid residues capable of attaining a posi-
tive charge and 10 amino acid residues capable of attaching
a negative charge (Brange, 1987). These properties are,
therefore, possibly responsible for the entrapment of insu-
lin into alginate/chitosan nanoparticles.
B. Sarmento et al. / Carbohydrate Polymers 66 (2006) 1–7 74. Conclusion
DSC and FTIR were successfully used to characterize
the nanoparticulate systems made up by polyelectrolyte
complexes. Shifts on endothermic and exothermic peaks
and shifts on maximum infrared peaks observed between
individual polyelectrolytes and final nanoparticle carriers
were understand as ionic interactions which led to the for-
mation of new chemical entities with different thermal and
absorption properties. Additionally, insulin entrapment
also originated small shifts on same nanoparticle peaks, a
clear influence of the protein on final formulation as an
entrapped drug.
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